EUVIMEDEUVIMED entdecken
Crossref

Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis

Yongmei Liu, Mengzhu Zhao, Lei Zhang, Jing Luo, Linlin Cheng, Haoting Zhan, Mansheng Li, Zijuan Zhang, Siyu Wang, Xinxin Feng, Min Feng, Haolong Li und 5 weitere

Annals of the Rheumatic Diseases · 2025

DOI: 10.1016/j.ard.2025.06.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von Yongmei Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Med…. Hauptthemen laut MEDLINE: Polychondritis, Relapsing, Autoantibodies. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The lack of effective biomarkers for relapsing polychondritis (RP) poses a significant challenge in its early diagnosis and treatment. This study aimed to identify novel autoantibodies and elucidate the pathogenesis and molecular heterogeneity of RP. METHODS: Plasma samples from 467 RP patients, 164 healthy controls (HCs), and 186 disease controls (DCs) were analysed using 2 sequential microarrays and enzyme-linked immunosorbent assay to sequentially discover, validate, and verify new autoantibodies. Machine learning and differential analysis were used to identify diagnosis-specific autoantibodies and their correlation with disease activity, recurrence, and remission. RESULTS: The RP group had 1344 elevated autoantibodies, discriminating RP patients from HCs. These antigenic targets were associated with pathways involving autoimmune responses, infections, and cardiovascular lesions. Two molecular subtypes characterised by distinct organ involvement and prognosis highlighted the heterogeneity of RP. Notably, 14 new autoantibodies were identified, which differentiated RP versus HCs and DCs with a sensitivity of 41% and 49.7% and a specificity of 91.7% and 90.5%, respectively. Among them, 6 autoantibodies showed better diagnostic performance and were consistently verified. Specifically, anti-C4B was positively correlated with disease activity, and increased anti-KRT16 predicted RP recurrence within 1 year. In addition, anti-C4B, anti-FNBP4, and anti-KRT10 decreased from acute attack to remission. Furthermore, the deposition of C4B protein in tracheal tissues, coupled with its reduction in plasma of RP patients, indicated that abnormal complement activation might be related to the pathological mechanism of RP. CONCLUSIONS: The 14 autoantibodies promoted a noninvasive early detection of RP, predicted disease recurrence and provided new insights into the understanding of RP pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polychondritis, RelapsingAutoantibodiesHumansBiomarkersFemaleMaleMiddle AgedAdultCase-Control StudiesEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityAgedMachine LearningPrognosis

Substanzen

AutoantibodiesBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Laboratory, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Rheumatology and Clinical Immunology, Department of Rheumatology, Peking Union Medica…
  • Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, China.
  • Department of Pathology, State Key Laboratory of Complex Severe and Rare Diseases, Molecular Pathology Research Centre, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical…

Förderung

  • National High Level Hospital Clinical Research Funding
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National Science Foundation of China

Zitieren

APA

Liu, Y., Zhao, M., Zhang, L., Luo, J., Cheng, L., Zhan, H., Li, M., Zhang, Z., Wang, S., Feng, X., Feng, M., Li, H., Li, Z., Zhang, J., Hou, Y., Yu, X., & Li, Y. (2025). Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.06.001

Vancouver

Liu Y, Zhao M, Zhang L, Luo J, Cheng L, Zhan H, et al. Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.06.001

BibTeX
@article{Liu2025,
  author = {Liu, Yongmei and Zhao, Mengzhu and Zhang, Lei and Luo, Jing and Cheng, Linlin and Zhan, Haoting and Li, Mansheng and Zhang, Zijuan and Wang, Siyu and Feng, Xinxin and Feng, Min and Li, Haolong and Li, Zhan and Zhang, Jingdi and Hou, Yong and Yu, Xiaobo and Li, Yongzhe},
  title = {Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis},
  journal = {Annals of the Rheumatic Diseases},
  year = {2025},
  doi = {10.1016/j.ard.2025.06.001}
}
Kostenlos starten →